Delstrigo Interactions
There are 374 drugs known to interact with Delstrigo (doravirine/lamivudine/tenofovir disoproxil), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 156 are major, 151 are moderate, and 67 are minor.
- View all 374 medications that may interact with Delstrigo
- View Delstrigo alcohol/food interactions (2)
- View Delstrigo disease interactions (9)
Most frequently checked interactions
View interaction reports for Delstrigo (doravirine / lamivudine / tenofovir disoproxil) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- alprazolam
- amlodipine
- aspirin
- atorvastatin
- Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- bupropion
- cyclobenzaprine
- Descovy (emtricitabine / tenofovir alafenamide)
- diazepam
- famotidine
- fenofibrate
- fluoxetine
- hydrochlorothiazide
- ibuprofen
- Intelence (etravirine)
- lisinopril
- lorazepam
- losartan
- magnesium glycinate
- montelukast
- naproxen
- omeprazole
- Pifeltro (doravirine)
- pregabalin
- promethazine
- ritonavir
- rosuvastatin
- valacyclovir
- Vitamin D3 (cholecalciferol)
Delstrigo alcohol/food interactions
There are 2 alcohol/food interactions with Delstrigo (doravirine / lamivudine / tenofovir disoproxil).
Delstrigo disease interactions
There are 9 disease interactions with Delstrigo (doravirine / lamivudine / tenofovir disoproxil) which include:
- hepatitis B
- hepatotoxicity
- pancreatitis
- liver dysfunction
- renal dysfunction
- renal dysfunction
- bone toxicity
- liver disease
- renal dysfunction
More about Delstrigo (doravirine / lamivudine / tenofovir disoproxil)
- Delstrigo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.